BIOMAT Database Logo BIOMAT Database Logo

Effects of cyclosporine A on chronic renal transplant rejection. 1994

R C Pabico, and J Yarger, and B Byer, and M Kremer, and B A McKenna, and G J Cerilli
Department of Medicine, University of Rochester School of Medicine and Dentistry, New York.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections

Related Publications

R C Pabico, and J Yarger, and B Byer, and M Kremer, and B A McKenna, and G J Cerilli
Chronic renal transplant rejection.
June 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation,
R C Pabico, and J Yarger, and B Byer, and M Kremer, and B A McKenna, and G J Cerilli
Chronic renal allograft rejection and cyclosporine.
October 1988, Transplantation proceedings,
R C Pabico, and J Yarger, and B Byer, and M Kremer, and B A McKenna, and G J Cerilli
Diagnosis of renal transplant rejection in the cyclosporine era.
December 1992, Current opinion in nephrology and hypertension,
R C Pabico, and J Yarger, and B Byer, and M Kremer, and B A McKenna, and G J Cerilli
Immunobiology of chronic renal transplant rejection.
January 1995, Blood purification,
R C Pabico, and J Yarger, and B Byer, and M Kremer, and B A McKenna, and G J Cerilli
Use of cyclosporine in chronic renal allograft rejection.
November 1988, Transplantation,
R C Pabico, and J Yarger, and B Byer, and M Kremer, and B A McKenna, and G J Cerilli
Delayed acute rejection episodes in cyclosporine-treated renal transplant recipients.
April 1985, Annals of surgery,
R C Pabico, and J Yarger, and B Byer, and M Kremer, and B A McKenna, and G J Cerilli
Acute cellular rejection or Cyclosporine A nephrotoxicity? A review of transplant renal biopsies.
September 1984, American journal of kidney diseases : the official journal of the National Kidney Foundation,
R C Pabico, and J Yarger, and B Byer, and M Kremer, and B A McKenna, and G J Cerilli
Indicators of acute renal-transplant rejection in patients treated with cyclosporine.
May 1990, Clinical chemistry,
R C Pabico, and J Yarger, and B Byer, and M Kremer, and B A McKenna, and G J Cerilli
Effects of dietary protein in patients with chronic renal transplant rejection.
January 1992, Kidney international,
R C Pabico, and J Yarger, and B Byer, and M Kremer, and B A McKenna, and G J Cerilli
Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.
February 1989, Transplantation proceedings,
Copied contents to your clipboard!